SPY443.91+0.73 0.16%
DIA347.87+0.31 0.09%
IXIC15,047.70-4.55 -0.03%

Cantor Fitzgerald Initiates Coverage On ATAI Life Sciences with Overweight Rating, Announces Price Target of $45

Cantor Fitzgerald analyst Charles Duncan initiates coverage on ATAI Life Sciences (NASDAQ:ATAI) with a Overweight rating and announces Price Target of $45.

Benzinga · 07/13/2021 08:30
Cantor Fitzgerald analyst Charles Duncan initiates coverage on ATAI Life Sciences (NASDAQ:ATAI) with a Overweight rating and announces Price Target of $45.